Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Colorectal Neoplasms 9Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Squamous Cell Carcinoma of Head and Neck 4Neoplasm Metastasis 4Solid Tumors 2Rectal Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumor, Adult 1Prostatic Neoplasms 1Kidney Neoplasms 1KRAS and NRAS Wild-type Colorectal Cancer 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Adenosquamous 1Carcinoma 1Advanced Solid Tumors 1

Interventions

Paclitaxel 12Gemcitabine 9atezolizumab 8Carboplatin 8Bevacizumab 6tocilizumab 4navitoclax 4liposomal doxorubicin 4Irinotecan 4Erlotinib Hydrochloride 4Cetuximab 4Sunitinib 3Oxaliplatin 3Leucovorin 3Injections 3Fluorouracil 3Docetaxel 3Cyclophosphamide 3tumor necrosis factor-alpha, CNGRC fusion protein, human 2tislelizumab 2temsirolimus 2ridaforolimus 2plocabulin 2pembrolizumab 2pazopanib 2olaparib 2obinutuzumab 2linifanib 2fludarabine 2envafolimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Solid Tumors × Panitumumab × Clear all
NCT00658658 2016-05-18

Panitumumab in Children With Solid Tumors

Amgen

Phase 1 Completed
31 enrolled 19 charts
Other solid neoplasm

Solid Tumors

NCT00586443 2014-11-19

BEP

Duke University

Phase 1 Completed
56 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡